Assenagon Asset Management S.A.

Position in AXSM — Axsome Therapeutics, Inc.

CIK 1546007 SENNINGERBERG, N4

Position in AXSM

as of Jun 30, 2026 · filed Jul 8, 2026 Compact

Position Value

$111,292,513

-$35,071,708 QoQ

Shares Held

454,682

-47.5% QoQ

Ownership

0.868%

of shares outstanding

% of Portfolio

0.15%

of 13F equity value

Holder Rank

#20

of 494 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Assenagon Asset Management S.A. holds $1,943,463,989 across 69 Biotechnology names. AXSM ranks #4 (5.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	759,564	$377,298,225
2	ROIV	Roivant Sciences Ltd.	8,362,952	$295,964,871
3	REGN	Regeneron Pharmaceuticals, Inc.	244,927	$152,721,781
4	AXSM	Axsome Therapeutics, Inc. This page	454,682	$111,292,513
5	BMRN	Biomarin Pharmaceutical Inc	1,762,086	$100,826,560
6	HALO	Halozyme Therapeutics, Inc.	997,643	$78,085,517
7	MDGL	Madrigal Pharmaceuticals, Inc.	124,214	$66,696,707
8	TARS	Tarsus Pharmaceuticals, Inc.	947,495	$59,635,335

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$111,292,513	454,682	-47.5%	Shares	Sole	2026-07-08
2026-03-31	$146,364,221	865,958	+85.0%	Shares	Sole	2026-04-20
2025-12-31	$85,472,232	467,982	+58.8%	Shares	Sole	2026-01-09
2025-09-30	$35,799,937	294,771	+62.9%	Shares	Sole	2025-10-07
2025-06-30	$18,890,414	180,960	-71.2%	Shares	Sole	2025-07-11
2025-03-31	$73,175,761	627,418	+16852.7%	Shares	Sole	2025-04-15
2024-12-31	$313,141	3,701	-17.4%	Shares	Sole	2025-01-14
2024-09-30	$402,887	4,483	-86.8%	Shares	Sole	2024-10-23
2024-06-30	$2,734,504	33,969	—	Shares	Sole	2024-07-18
No filing history on record for this holder in this stock.